Skip to main content
Log in

Hepatic CYP3A expression and activity in low birth weight developing female rats

  • Original Article
  • Published:
World Journal of Pediatrics Aims and scope Submit manuscript

Abstract

Background

We aimed to investigate the effects of low birth weight (LBW) on the hepatic expression of cytochrome P-450 3A (CYP3A) in developing female rats.

Methods

Pregnant rats were divided into two groups, a nourished group and an under-nourished group. The offspring of the nourished rats were defined as a normal weight, normal diet group (NN group). The offspring of the under-nourished rats were designated as a LBW, normal diet group (LN group). CYP3A mRNA expression, protein expression, protein localization and activity were determined.

Results

The CYP3A1 mRNA expression levels of the LN group on days 3, 21, and 56 were significantly higher than those of the same age in the NN group (P≤0.01). The mRNA expression of CYP3A2 in the LN group on day 21 was higher than in rats of the same age in the NN group (P<0.01). The staining intensity and frequency of CYP3A1-positive hepatocytes were significantly lower on days 7 and 21 in the LN group than those of rats of the same age in the NN group (P<0.05). The staining intensity and frequency of CYP3A2-positive hepatocytes on days 14 and 21 were higher in the LN group than those on the same days in the NN group (P<0.05). The mean CYP3A activity of the LN group on day 3 was significantly higher than that of the NN group (P<0.001).

Conclusions

We found the effect of LBW on CYP3A activity was most prominent during the early days of life in rats. Investigators and clinicians should consider the effect of LBW on CYP3A in both pharmacokinetic study design and data interpretation, when prescribing drugs to LBW infants.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Barker DJ. Fetal origins of coronary heart disease. Br Heart J 1993;69:195–196.

    Article  PubMed  CAS  Google Scholar 

  2. Wang XM. Early life programming and metabolic syndrome. World J Pediatr 2013;9:5–8.

    Article  PubMed  Google Scholar 

  3. Arantes VC, Teixeira VP, Reis MA, Latorraca MQ, Leite AR, Carneiro EM, et al. Expression of PDX-1 is reduced in pancreatic islets from pups of rat dams fed a low protein diet during gestation and lactation. J Nutr 2002;132:3030–3035.

    PubMed  CAS  Google Scholar 

  4. Yoshinari K, Takagi S, Yoshimasa T, Sugatani J, Miwa M. Hepatic CYP3A expression is attenuated in obese mice fed a high-fat diet. Pharm Res 2006;23:1188–1200.

    Article  PubMed  CAS  Google Scholar 

  5. Pojda J, Kelley L, editors. ACC/SCN Nutrition Policy Paper #18. A report based on the International Low Birthweight Symposium and Workshop. 1999 June 14–17; Dhaka, Bangladesh.

    Google Scholar 

  6. Stevens JC, Hines RN, Gu C, Koukouritaki SB, Manro JR, Tandler PJ, et al. Developmental expression of the major human hepatic CYP3A enzymes. J Pharmacol Exp Ther 2003;307:573–582.

    Article  PubMed  CAS  Google Scholar 

  7. Johnson TN. The development of drug metabolising enzymes and their influence on the susceptibility to adverse drug reactions in children. Toxicology 2003;192:37–48.

    Article  PubMed  CAS  Google Scholar 

  8. Yu AM, Fukamachi K, Krausz KW, Cheung C, Gonzalez FJ. Potential role for human cytochrome P450 3A4 in estradiol homeostasis. Endocrinology 2005;146:2911–2919.

    Article  PubMed  CAS  Google Scholar 

  9. Pikuleva IA. Cytochrome P450s and cholesterol homeostasis. Pharmacol Ther 2006;112:761–773.

    Article  PubMed  CAS  Google Scholar 

  10. Thummel KE, Wilkinson GR. In vitro and in vivo drug interactions involving human CYP3A. Annu Rev Pharmacol Toxicol 1998;38:389–430.

    Article  PubMed  CAS  Google Scholar 

  11. Ni S, Wang X, Wang J, Lu S, Zeng S, Zhao Z, et al. Effects of intrauterine undernutrition on the expression of CYP3A23/3A1, PXR, CAR and HNF4alpha in neonate rats. Biopharm Drug Dispos 2008;29:501–510.

    Article  PubMed  CAS  Google Scholar 

  12. Anakk S, Huang W, Staudinger JL, Tan K, Cole TJ, Moore DD, et al. Gender dictates the nuclear receptor-mediated regulation of CYP3A44. Drug Metab Dispos 2007;35:36–42.

    Article  PubMed  CAS  Google Scholar 

  13. Cooper KO, Reik LM, Jayyosi Z, Bandiera S, Kelley M, Ryan DE, et al. Regulation of two members of the steroid-inducible cytochrome P450 subfamily (3A) in rats. Arch Biochem Biophys 1993;301:345–354.

    Article  PubMed  CAS  Google Scholar 

  14. Mahnke A, Strotkamp D, Roos PH, Hanstein WG, Chabot GG, Nef P. Expression and inducibility of cytochrome P450 3A9 (CYP3A9) and other members of the CYP3A subfamily in rat liver. Arch Biochem Biophys 1997;337:62–68.

    Article  PubMed  CAS  Google Scholar 

  15. Ni S, Wang X, Wang J, Zhao Z, Zeng S. The effects of a highfat and high-energy diet on the hepatic expression of CYP3A in developing female rats. Xenobiotica 2012;42:587–595.

    Article  PubMed  CAS  Google Scholar 

  16. Ni S, Wang X, Wang J, Zeng S, Zhao Z. Expression of CYP3A23/1, CYP3A2, PXR, CAR and HNF4alpha in large-forgestational-age neonatal rats. Pharmazie 2009;64:252–257.

    PubMed  CAS  Google Scholar 

  17. Lee CH, Lee MK, Kang CD, Kim YD, Park DY, Kim JY, et al. Differential expression of hypoxia inducible factor-1 alpha and tumor cell proliferation between squamous cell carcinomas and adenocarcinomas among operable non-small cell lung carcinomas. J Korean Med Sci 2003;18:196–203.

    PubMed  CAS  Google Scholar 

  18. Johnson TN, Tanner MS, Tucker GT. A comparison of the ontogeny of enterocytic and hepatic cytochromes P450 3A in the rat. Biochem Pharmacol 2000;60:1601–1610.

    Article  PubMed  CAS  Google Scholar 

  19. Michaud J, Leblond FA, Naud J, Boisvert C, Desbiens K, Nicoll-Griffith DA, et al. Use of a fluorescent substrate for the selective quantification of rat CYP3A in the liver and the intestine. J Pharmacol Toxicol Methods 2007;55:209–213.

    Article  PubMed  CAS  Google Scholar 

  20. de Wildt SN, Kearns GL, Leeder JS, van den Anker JN. Cytochrome P450 3A: ontogeny and drug disposition. Clin Pharmacokinet 1999;37:485–505.

    Article  PubMed  Google Scholar 

  21. Hakkola J, Tanaka E, Pelkonen O. Developmental expression of cytochrome P450 enzymes in human liver. Pharmacol Toxicol 1998;82:209–217.

    Article  PubMed  CAS  Google Scholar 

  22. Wu G, Bazer FW, Cudd TA, Meininger CJ, Spencer TE. Maternal nutrition and fetal development. J Nutr 2004;134:2169–2172.

    PubMed  CAS  Google Scholar 

  23. Anderson BJ, Holford NH. Mechanistic basis of using body size and maturation to predict clearance in humans. Drug Metab Pharmacokinet 2009;24:25–36.

    Article  PubMed  CAS  Google Scholar 

  24. Desai M, Hales CN. Role of fetal and infant growth in programming metabolism in later life. Biol Rev Camb Philos Soc 1997;72:329–348.

    Article  PubMed  CAS  Google Scholar 

  25. Vonnahme KA, Hess BW, Hansen TR, McCormick RJ, Rule DC, Moss GE, et al. Maternal undernutrition from early-to mid-gestation leads to growth retardation, cardiac ventricular hypertrophy, and increased liver weight in the fetal sheep. Biol Reprod 2003;69:133–140.

    Article  PubMed  CAS  Google Scholar 

  26. Ojeda SR, Jameson HE. Developmental patterns of plasma and pituitary growth hormone (GH) in the female rat. Endocrinology 1977;100:881–889.

    Article  PubMed  CAS  Google Scholar 

  27. Kim H, Putt DA, Zangar RC, Wolf CR, Guengerich FP, Edwards RJ, et al. Differential induction of rat hepatic cytochromes P450 3A1, 3A2, 2B1, 2B2, and 2E1 in response to pyridine treatment. Drug Metab Dispos 2001;29:353–360.

    PubMed  CAS  Google Scholar 

  28. Huss JM, Wang SI, Kasper CB. Differential glucocorticoid responses of CYP3A23 and CYP3A2 are mediated by selective binding of orphan nuclear receptors. Arch Biochem Biophys 1999;372:321–332.

    Article  PubMed  CAS  Google Scholar 

  29. Glöckner R, Karge E. Postnatal development of body mass and of hepatic xenobiotics biotransformation of male rats with low body mass at birth. Exp Toxicol Pathol 1993;45:145–148.

    Article  PubMed  Google Scholar 

  30. Quattrochi LC, Guzelian PS. Cyp3A regulation: from pharmacology to nuclear receptors. Drug Metab Dispos 2001;29:615–622.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Su Zeng.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zhu, ZW., Ni, SQ., Wang, XM. et al. Hepatic CYP3A expression and activity in low birth weight developing female rats. World J Pediatr 9, 266–272 (2013). https://doi.org/10.1007/s12519-013-0429-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12519-013-0429-x

Key words

Navigation